Literature DB >> 26751915

Are plasma mineral levels related to antibody response to influenza vaccination in older adults?

Ata Murat Kaynar1,2, Mary Patricia Nowalk3, Chyongchiou Jeng Lin3, Krissy K Moehling3, Michael Susick3, Veli Bakalov4, Bruce R Pitt4, Daniel J Bain5, Ted M Ross6, Sean G Saul3, Mahlon Raymund3, Richard K Zimmerman3.   

Abstract

INTRODUCTION: An effective immune response to vaccination may be related to nutritional status. This study examined the association of plasma mineral levels with hemagglutination inhibition (HI) titers produced in response to influenza vaccine in older adults.
METHODS: Prior to (Day 0) and 21 (range = 19-28) days after receiving the 2013-14 influenza vaccine, 109 adults ages 51-81 years, provided blood samples. Serum samples were tested for HI activity against the A/H1N1 and A/H3N2 2013-2014 vaccine virus strains. Plasma minerals were collected in zinc-free tubes and assayed by inductively coupled plasma mass spectrometry. HI titers were reported as seroprotection (≥1:40) and seroconversion (≥ 4-fold rise from Day 0 (minimum HI = 1:10) to Day 21). Both HI titers and mineral values were skewed and thus log2 transformed. Magnesium (Mg), phosphorus (P), zinc (Zn), copper (Cu), iron (Fe), potassium (K) and the Cu to Zn ratio were tested. Logistic regression analyses were used to determine the associations between mineral levels and seroconversion and seroprotection of HI titers for each influenza A strain.
RESULTS: Participants were 61% white, 28% male, 39% diabetic, and 81% overweight/obese with a mean age of 62.6 y. In logistic regression, Day 21 A/H1N1 seroprotection was associated with P and Zn at Day 21(P < 0.05). Seroconversion of A/H1N1 was associated with Day 21 Cu, P, and Mg (P < 0.03). Day 21 A/H3N2 seroprotection and seroconversion were associated with Day 21 P (P < 0.05).
CONCLUSIONS: Phosphorus was associated with seroprotection and seroconversion to influenza A after vaccination; these associations warrant additional studies with larger, more diverse population groups.

Entities:  

Keywords:  immunogenicity; influenza vaccine; plasma minerals

Mesh:

Substances:

Year:  2016        PMID: 26751915      PMCID: PMC4962950          DOI: 10.1080/21645515.2015.1113358

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  26 in total

Review 1.  Promoting influenza vaccination: insights from a qualitative meta-analysis of 14 years of influenza-related communications research by U.S. Centers for Disease Control and Prevention (CDC).

Authors:  Glen J Nowak; Kristine Sheedy; Kelli Bursey; Teresa M Smith; Michelle Basket
Journal:  Vaccine       Date:  2015-04-28       Impact factor: 3.641

2.  Naïve and central memory T-cell lymphopenia in end-stage renal disease.

Authors:  J-W Yoon; S Gollapudi; M V Pahl; N D Vaziri
Journal:  Kidney Int       Date:  2006-05-31       Impact factor: 10.612

3.  Serum selenium and zinc levels in critically ill surgical patients.

Authors:  Ji Young Jang; Hongjin Shim; Seung Hwan Lee; Jae Gil Lee
Journal:  J Crit Care       Date:  2013-12-12       Impact factor: 3.425

4.  Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2011.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2011-08-26       Impact factor: 17.586

5.  Association between obesity and vulnerability and serologic response to influenza vaccination in older adults.

Authors:  H K Talbot; L A Coleman; K Crimin; Y Zhu; M T Rock; J Meece; D K Shay; E A Belongia; M R Griffin
Journal:  Vaccine       Date:  2012-04-03       Impact factor: 3.641

Review 6.  Chemokines as regulators of T cell differentiation.

Authors:  S A Luther; J G Cyster
Journal:  Nat Immunol       Date:  2001-02       Impact factor: 25.606

7.  Phosphate modulates receptor sulfotyrosine recognition by the chemokine monocyte chemoattractant protein-1 (MCP-1/CCL2).

Authors:  Justin P Ludeman; Mahdieh Nazari-Robati; Brendan L Wilkinson; Cheng Huang; Richard J Payne; Martin J Stone
Journal:  Org Biomol Chem       Date:  2015-02-21       Impact factor: 3.876

8.  The impact of immunosenescence on humoral immune response variation after influenza A/H1N1 vaccination in older subjects.

Authors:  Iana H Haralambieva; Scott D Painter; Richard B Kennedy; Inna G Ovsyannikova; Nathaniel D Lambert; Krista M Goergen; Ann L Oberg; Gregory A Poland
Journal:  PLoS One       Date:  2015-03-27       Impact factor: 3.240

9.  Impact of aging on calcium influx and potassium channel characteristics of T lymphocytes.

Authors:  Szonja Kollár; László Berta; Zsófia Eszter Vásárhelyi; Attila Balog; Barna Vásárhelyi; János Rigó; Gergely Toldi
Journal:  Oncotarget       Date:  2015-05-30

10.  Prevalence and possible causes of anemia in the elderly: a cross-sectional analysis of a large European university hospital cohort.

Authors:  Veronika Bach; Guenter Schruckmayer; Ines Sam; Georg Kemmler; Reinhard Stauder
Journal:  Clin Interv Aging       Date:  2014-07-22       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.